Insulet Corporation (PODD) PT Raised to $303 at Morgan Stanley
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $148.03 +5.96%
Rating Summary:
22 Buy, 17 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
22 Buy, 17 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Morgan Stanley analyst David Lewis raised the price target on Insulet Corporation (NASDAQ: PODD) to $303.00 (from $276.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Bloom Energy Corporation (NYSE: BE); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO); and Insulet Corporation (NASD
- DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
- CrowdStrike (CRWD) PT Raised to $250 at Benchmark Ahead of Q2 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
